Overview

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This non-interventional study is to monitor use in real practice in Korea including adverse events on Aromasin (Exemestane).

Details

Lead Sponsor:

Pfizer

Treatments:

Exemestane